Daily News for Dealmakers
2021 brought a flurry of #MnA activity in the life sciences sector, followed by a slowdown in 2022. Here’s why dealmaking could pick up again. deloi.tt/3PIOHZP
– Deloitte M&A (@DeloitteMnA)09:00 – Aug 31, 2022
Strategic Investment: CVC Capital Partners targets €700 million fundraising for Genetic, a leading Italian pharmaceutical outsourcing company, to drive organic and inorganic growth. Industry...
Strategic Focus: The merger between AlloVir and Kalaris Therapeutics creates a biotech entity laser-focused on developing innovative treatments for retinal diseases like neovascular age-related...
Strategic Consolidation: AlloVir and Kalaris Therapeutics merge to create a biotech powerhouse focused on retinal disease treatments. Market Potential: The global retinal disease market is projected...
Strategic Acquisition: Boston Scientific's acquisition of Cortex, Inc. expands its electrophysiology portfolio with the OptiMap System, a diagnostic mapping solution for complex atrial fibrillation...